
Pyridam Farma Tbk PT
IDX:PYFA

Intrinsic Value
The intrinsic value of one
PYFA
stock under the Base Case scenario is
191.95
IDR.
Compared to the current market price of 206 IDR,
Pyridam Farma Tbk PT
is
Overvalued by 7%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Pyridam Farma Tbk PT
Fundamental Analysis


Revenue & Expenses Breakdown
Pyridam Farma Tbk PT
Balance Sheet Decomposition
Pyridam Farma Tbk PT
Current Assets | 1.5T |
Cash & Short-Term Investments | 353.5B |
Receivables | 653B |
Other Current Assets | 530.6B |
Non-Current Assets | 4.3T |
Long-Term Investments | 77B |
PP&E | 1.5T |
Intangibles | 2.6T |
Other Non-Current Assets | 78.1B |
Free Cash Flow Analysis
Pyridam Farma Tbk PT
IDR | |
Free Cash Flow | IDR |
Earnings Waterfall
Pyridam Farma Tbk PT
Revenue
|
1.9T
IDR
|
Cost of Revenue
|
-1.4T
IDR
|
Gross Profit
|
536.5B
IDR
|
Operating Expenses
|
-646.2B
IDR
|
Operating Income
|
-109.7B
IDR
|
Other Expenses
|
-220.5B
IDR
|
Net Income
|
-330.2B
IDR
|
PYFA Profitability Score
Profitability Due Diligence
Pyridam Farma Tbk PT's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

Score
Pyridam Farma Tbk PT's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
PYFA Solvency Score
Solvency Due Diligence
Pyridam Farma Tbk PT's solvency score is 21/100. The higher the solvency score, the more solvent the company is.

Score
Pyridam Farma Tbk PT's solvency score is 21/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PYFA Price Targets Summary
Pyridam Farma Tbk PT
Dividends
Current shareholder yield for PYFA is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
PYFA
stock under the Base Case scenario is
191.95
IDR.
Compared to the current market price of 206 IDR,
Pyridam Farma Tbk PT
is
Overvalued by 7%.